What Is a Brain Tumor?
A brain tumor is a growth of abnormal cells inside the brain or in the tissues and structures very close to it, such as the membranes covering the brain, the pituitary gland, the pineal gland, or the cranial nerves. Unlike normal cells, which grow in an orderly, controlled way, tumor cells multiply without following the body's usual rules.
The most important thing to understand right away: a brain tumor diagnosis is not automatically a death sentence. Many brain tumors are slow-growing and entirely treatable. Even in complex cases, modern neurosurgery, radiation, and medical therapies have dramatically changed what is possible. The goal of this page is to help you understand what type of tumor you or your loved one is dealing with — because that single fact shapes everything else.
More than 150 different types of brain tumors have been identified. Knowing the specific type and grade is the most important step before any treatment decision is made.
Brain tumors are broadly classified as primary (starting in the brain itself) or secondary/metastatic (spreading to the brain from cancer elsewhere in the body such as the lung, breast, or skin). Primary brain tumors are much less common — affecting roughly 25 per 100,000 people each year — while metastatic tumors are more frequent. Each type behaves differently and requires a different approach.
Common Types of Brain Tumors
Here is a plain-language overview of the brain tumor types your doctor is most likely to discuss:
Gliomas arise from the glial cells — the supportive tissue of the brain. They range from very slow-growing (low-grade glioma, astrocytoma) to aggressive (glioblastoma, also called GBM). Glioblastoma is the most common malignant primary brain tumor in adults. It is challenging, but specialised centres perform highly sophisticated surgery and treatment that can extend good-quality life meaningfully.
Meningiomas grow from the meninges — the three-layered membrane that wraps the brain and spinal cord. They are the most common primary brain tumor overall and are benign (non-cancerous) in about 90% of cases. Many small meningiomas are watched over time without immediate surgery and remain stable for years. Larger or symptomatic ones are treated very successfully with surgery.
These grow in the pituitary gland at the base of the brain. They are almost always benign and frequently curable. They may cause hormonal changes (excess or deficiency of hormones) or vision disturbance by pressing on the optic nerves. Most are treated through the nose without any scalp incision.
A benign tumor on the nerve connecting the ear to the brain. Symptoms include one-sided hearing loss, ringing in the ear, or balance problems. Small ones can be monitored; larger ones are treated with surgery or stereotactic radiosurgery (a precise radiation technique).
These are more common in children. Medulloblastoma is a fast-growing tumor of the cerebellum (the back of the brain that controls balance). With combined surgery, radiation, and chemotherapy, cure rates for certain subtypes reach 70–80%.
Cancer cells from another part of the body that travel through the bloodstream and settle in the brain. Treatment is tailored to both the primary cancer and the number and location of brain lesions. Surgery, radiosurgery, and targeted drug therapy can all play a role.
Symptoms: What to Watch For
Brain tumor symptoms depend on the location, size, and growth rate of the tumor rather than on whether it is malignant. A large benign tumor can cause severe symptoms, while a small malignant tumor in a "silent" area may cause none at first. Common symptoms include:
New or changed headache pattern, often worse in the morning or when lying down, sometimes waking you from sleep.
A new seizure in an adult with no prior history should always prompt a brain scan, even if it resolves on its own.
Blurring, double vision, or loss of part of the visual field in one or both eyes.
Difficulty finding words, slurring speech, or trouble understanding what others say.
Weakness in an arm or leg, facial drooping, or numbness on one side of the body.
Unusual mood swings, memory lapses, confusion, or difficulty with concentration — often noticed first by family members.
Unsteady gait, clumsiness, or coordination difficulties, especially with posterior fossa tumors.
Especially in the morning, or not related to eating, due to raised intracranial pressure.
A new seizure, sudden severe headache unlike any before, rapid deterioration in vision, weakness, or speech — these warrant same-day medical evaluation. Do not wait to see if symptoms go away on their own.
How a Brain Tumor Is Diagnosed
Diagnosis involves several steps. Modern imaging is remarkably accurate, and a tissue biopsy or surgical specimen confirms the exact tumor type.
- 1
MRI Brain with Contrast — The most important first test. An MRI gives detailed images of the brain's soft tissue. "With contrast" means a dye (gadolinium) is injected into a vein to highlight abnormal tissue. It does not involve radiation. Functional MRI (fMRI) and diffusion tensor imaging (DTI) can also map speech and movement areas to plan safe surgery.
- 2
CT Scan — Faster than MRI and very useful in an emergency to check for bleeding or bone involvement. Often the first scan done when a patient arrives in the ER.
- 3
PET Scan — Uses a radioactive glucose tracer to show how metabolically active a tumor is. Helpful to distinguish aggressive from slow-growing tumors and to detect recurrence.
- 4
Neurological Examination — A careful clinical assessment of reflexes, vision, balance, coordination, and cognitive function maps which parts of the brain are affected.
- 5
Biopsy or Surgical Specimen — The only way to know the exact tumor type and molecular profile. A small tissue sample is examined under the microscope and tested for genetic markers (such as IDH mutation, MGMT promoter methylation, 1p/19q co-deletion) that directly influence treatment and prognosis.
Today's diagnosis goes beyond looking at tumor cells through a microscope. Genetic and molecular markers obtained from the tumor tissue tell us how the tumor will behave and which treatments are most likely to work — this is what is meant by "precision medicine" in neuro-oncology.
Tumor Grades: Understanding the Severity
The World Health Organization (WHO) grades brain tumors from Grade 1 to Grade 4 based on how abnormal the cells look and how quickly they are likely to grow. Grade is one of the most important factors in planning treatment.
| WHO Grade | Description | Examples | Growth Rate |
|---|---|---|---|
| Grade I | Cells look nearly normal; slow growth; often curable with surgery alone | Pilocytic astrocytoma, Craniopharyngioma | Very Slow |
| Grade II | Mildly abnormal cells; slow growing but may progress over years | Diffuse astrocytoma, Oligodendroglioma | Slow |
| Grade III | Clearly abnormal cells; actively dividing; tends to recur | Anaplastic astrocytoma, Anaplastic oligodendroglioma | Moderate |
| Grade IV | Highly abnormal cells; aggressive; rapid growth; most malignant | Glioblastoma (GBM), Diffuse midline glioma | Aggressive |
Molecular markers, patient age, functional status, and the tumor's location all influence how treatment is planned and what outcomes are possible. Two Grade IV tumors in two different patients may behave very differently based on their genetic profiles.
Treatment Options
Brain tumor treatment is almost never one-size-fits-all. A multidisciplinary team — including a neurosurgeon, neuro-oncologist, radiation oncologist, neurologist, and pathologist — reviews each case together. The main treatment modalities are:
Surgery (Craniotomy / Minimally Invasive Approaches)
Surgery is usually the first and most important step. Removing as much tumor as safely possible (called "maximal safe resection") reduces pressure on the brain, confirms the diagnosis, and makes other treatments work better. Modern techniques including intraoperative MRI, fluorescent dye-guided surgery (5-ALA), awake craniotomy, and neuronavigation allow surgeons to remove tumors that were considered inoperable just a decade ago. Surgery should not be feared — it should be understood.
Radiation Therapy
High-energy radiation targeted precisely at tumor cells while sparing surrounding healthy brain. Modern techniques include intensity-modulated radiation therapy (IMRT), proton beam therapy, and stereotactic radiosurgery (SRS) — the latter delivering a precise high dose in a single or few sessions with no incision (e.g., Gamma Knife, CyberKnife, Novalis). Radiosurgery is especially effective for metastases, acoustic neuromas, and meningiomas.
Chemotherapy
Certain brain tumors respond well to chemotherapy. Temozolomide (TMZ) is the standard drug used alongside radiation for glioblastoma. For oligodendroglioma — a type with a specific chromosome change — chemotherapy produces remarkable, lasting responses. Drugs are chosen based on the tumor's molecular profile, not just its appearance under the microscope.
Targeted Therapy & Immunotherapy
Newer drugs target specific genetic mutations in tumor cells, causing far less damage to normal tissue. Immunotherapy harnesses the body's own immune system to attack tumor cells. Clinical trials are testing these approaches in many brain tumor types, and results are progressively improving.
Tumor Treating Fields (TTFields)
An innovative technology that uses low-intensity electrical fields — delivered through a wearable device — to disrupt tumor cell division. When added to standard treatment in glioblastoma, it has shown a meaningful improvement in survival in clinical trials.
Watchful Waiting (Active Surveillance)
For small, incidentally found, slow-growing tumors — particularly meningiomas in older patients with no symptoms — regular MRI monitoring without immediate intervention is often the safest and wisest approach. Not every brain tumor needs to be operated on right away.
Physical, occupational, and speech therapy after treatment can significantly restore lost function. Neuroplasticity — the brain's remarkable ability to reorganise and adapt — means that recovery often continues for months after surgery or radiation.
Brain Tumor Surgery: What to Expect
For many patients, the idea of surgery on the brain feels terrifying. But understanding what actually happens can replace fear with knowledge — and knowledge leads to better decisions.
Before Surgery
A detailed MRI is used to create a three-dimensional surgical plan. The surgical team reviews the exact location of the tumor in relation to critical areas like the motor strip (which controls movement), speech areas, and blood vessels. If the tumor is near a speech area, an awake craniotomy may be planned — you are gently woken during the critical part of the operation so that the team can speak with you and monitor speech in real time. This is not as frightening as it sounds; patients are kept comfortable throughout.
During Surgery
Most brain tumor surgeries take 3 to 8 hours. Under general anaesthesia, a section of the skull (a bone flap) is carefully removed to access the tumor. Using microscopes, navigational guidance, and sometimes fluorescent dyes that make tumor cells glow, the surgeon removes as much tumor as safely possible. The bone flap is then secured back in place, usually with small titanium plates and screws.
After Surgery
Most patients are in the ICU for 24–48 hours for monitoring, then moved to a regular ward. Hospital stay is typically 3–5 days for uncomplicated cases. Many patients are surprised by how quickly they recover. Mild headache and fatigue are normal; significant neurological deficits are uncommon when surgery is performed at a specialised centre. Return to daily activities usually begins within 2–6 weeks.
Volume matters. Surgeons and hospitals that perform a high number of brain tumor operations have measurably better outcomes. Do not hesitate to ask your surgeon how many procedures of this specific type they perform annually, and whether a second opinion would be appropriate.
The question I am asked most often before brain tumor surgery is: "Will I still be me after the operation?" It is the right question. Modern neurosurgery's central philosophy is that preserving the person matters as much as removing the tumor. Every decision we make — about approach, about how much to resect, about when to stop — is guided by the goal of keeping you cognitively intact, functional, and yourself.
I operate with intraoperative monitoring, awake techniques when needed, neuronavigation, and fluorescent dye guidance. These are not luxuries — they are the tools that let us take tumors out that were previously considered too dangerous to touch. If you have been told a tumor is inoperable, that opinion deserves a second look at a centre that has these capabilities.
Outcomes & Prognosis: A Realistic Picture
One of the hardest conversations in medicine involves prognosis — what to expect. Numbers in medical literature represent averages across large populations and do not predict what will happen to any single individual. With that in mind, here is an honest overview:
- Grade I tumors (e.g., pilocytic astrocytoma): Near-normal life expectancy with complete surgical removal.
- Meningioma (benign): Excellent outcomes. Recurrence after complete removal is uncommon.
- Oligodendroglioma (Grade II–III, IDH-mutant, 1p/19q co-deleted): Among the most treatable gliomas; many patients live 10–15+ years with treatment.
- IDH-mutant astrocytoma (Grade II–III): Slower course than IDH-wildtype; good response to combined therapy.
- Glioblastoma (Grade IV): Median survival with current standard treatment is 15–20 months; however, a meaningful subset of patients — particularly younger patients with favourable molecular markers and complete resection — achieve significantly longer survival. Research is advancing rapidly.
- Brain metastases: Increasingly treatable, especially with targeted therapies for specific cancer types.
Modern neurosurgical philosophy prioritises maintaining neurological function — keeping you able to work, drive, communicate, and enjoy your life — alongside tumor control. A longer survival achieved at the cost of who you are is not the goal. Preserving both is.
Watch: Defeating Difficult Brain Tumors
Our YouTube channel features an entire section on difficult brain tumor cases — including surgeries that other centres considered inoperable — explained in a way patients and families can understand.
Watch on YouTube →Questions to Ask Your Neurosurgeon
A well-prepared patient gets better care. Bring these questions to your first consultation:
- 1
What is the exact name, grade, and molecular profile of my tumor? — Understanding your specific diagnosis is the starting point of everything.
- 2
What are all my treatment options, and what are the pros and cons of each? — Including the option of observation, if appropriate.
- 3
What is the goal of surgery — cure, control, or symptom relief? — This shapes expectations and helps with decision-making.
- 4
How many of these surgeries do you perform each year? — Experience at your surgeon's level and at the institution level both matter.
- 5
What are the risks specific to my tumor's location? — Not all brain surgeries carry the same risks.
- 6
Are there clinical trials I might be eligible for? — Access to investigational treatments can sometimes offer options beyond the current standard of care.
- 7
What does recovery look like, and what support will I need? — Rehabilitation, driving restrictions, return to work, and medication management all need planning.
Any good neurosurgeon will support — and even encourage — you to seek a second opinion for a brain tumor diagnosis. It is not an insult; it is good medicine. Bring your MRI scans and all reports to any second consultation.
